In-Body Delivery Requires Tissue-Targeted Viruses

Delivering CRISPR into specific tissues in an intact body is hard because viral vectors tend to target only particular cell types; achieving whole-body coverage would require a cocktail of viruses, while the more realistic approach is delivering to specific organs like the liver or brain to treat disease localized to those cells.